about
The mouse and human Fli1 genes are similarly regulated by Ets factors in T cells.Deficiency of activating Fcγ-receptors reduces hepatic clearance and deposition of IC and increases CIC levels in mercury-induced autoimmunity.Regulatory effect of melatonin on cytokine disturbances in the pristane-induced lupus mice.A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis.Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.MicroRNA-let-7a expression is increased in the mesangial cells of NZB/W mice and increases IL-6 production in vitro.Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in Systemic Lupus ErythematosusIncreased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist.MicroRNAs implicated in the immunopathogenesis of lupus nephritis.Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment.IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.The ambiguity in immunology.Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.Inducible nitric oxide synthase inhibitors reduce urinary markers of systemic oxidant stress in murine proliferative lupus nephritis.Interleukin-6 deficiency corrects nephritis, lymphocyte abnormalities, and secondary Sjögren's syndrome features in lupus-prone Sle1.Yaa mice.Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort.Increased prevalence of activated CD70+CD4+ T cells in the periphery of patients with systemic lupus erythematosus.
P2860
Q33703361-697249D6-62DD-48A4-9595-1AE3440C0CD3Q33728412-2586174D-D666-4DCA-8913-433A7B0064D0Q34035588-3AD6FD1B-05CB-4ED4-9093-70352A594FF5Q34613976-C5909913-8AE9-4455-BEAE-307332B27C28Q34816243-941AB07A-B1C1-4B89-93BD-F6BE04B50B44Q35601698-9D49B729-EE5E-4FF0-A6A3-00D6ED1C7564Q35961658-F1BA28EC-2D8D-437D-99CB-C8EAED1D10CCQ36461786-08AEF30C-B2A6-45B3-8932-016F86B1AC8CQ37090412-709E88CC-1762-41C7-B2CB-5DBA8B0F53DAQ37403811-5BD846A1-DC84-40E3-9DDB-661A813EF15EQ37809053-A6480C12-35F1-4D4E-8823-214B560C5545Q38008353-DF4D5F72-5A8F-4E53-B190-9F7EE238CAB6Q39608198-52616715-CAB7-4998-A07A-5CB2C56216A2Q40371583-E10C5538-46C1-4005-BC94-37B2DE2F3396Q42845944-F4CD9088-206F-4344-94E8-259978F21D09Q43924407-0880604D-CC68-4FBB-A44B-AA1E7EDE9F1DQ51988658-2861C91F-F5F5-419A-8686-7285B43B1F0E
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mediators of injury in lupus nephritis.
@ast
Mediators of injury in lupus nephritis.
@en
Mediators of injury in lupus nephritis.
@nl
type
label
Mediators of injury in lupus nephritis.
@ast
Mediators of injury in lupus nephritis.
@en
Mediators of injury in lupus nephritis.
@nl
prefLabel
Mediators of injury in lupus nephritis.
@ast
Mediators of injury in lupus nephritis.
@en
Mediators of injury in lupus nephritis.
@nl
P1476
Mediators of injury in lupus nephritis.
@en
P2093
Gary S Gilkeson
Jim C Oates
P304
P356
10.1097/00002281-200209000-00003
P577
2002-09-01T00:00:00Z